Jump to content
Sclero Forums

Search the Community

Showing results for tags 'interstitial cystitis'.



More search options

  • Search By Tags

    Type tags separated by commas.
  • Search By Author

Content Type


Forums

  • Worldwide
    • Welcome: Guidelines and FAQs
    • Sclero Forums (MAIN)
    • UK Scleroderma
    • News
    • Personal Support

Blogs

  • CFM Babs from Chorley FM
  • barefut impressions
  • My Two Cents...
  • Amanda Thorpe's Blog
  • Joelf's Blog
  • Michael Thorpe's Blog

Find results in...

Find results that contain...


Date Created

  • Start

    End


Last Updated

  • Start

    End


Filter by number of...

Joined

  • Start

    End


Group


Location

Found 8 results

  1. New drug brings hope to as many as 400,000 sufferers of agonising bladder pain syndrome. As many as 400,000 people in UK are thought to have bladder pain syndrome, also known as interstitial cystitis. Mail Online, 10/26/2019. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  2. For Urinary Incontinence, Try Behavioral Treatments or Drugs, or Both. Bladder training, biofeedback and other behavioral therapies may work even better in combination with drugs. New York Times, 03/22/2019. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles. 
  3. Prevalence and disease–specific risk factors for Lower Urinary Tract symptoms (LUTS) in Systemic Sclerosis: an international multi–centric study. Self–reported LUTS are amongst the most frequent symptoms in SSc and are associated with digestive complaints. PubMed, Arthritis Care Res (Hoboken), 10/26/2017. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  4. The limited cutaneous form of systemic sclerosis (SSc) is associated with urinary incontinence (UI): an international multicentre study. Self–reported UI is frequent in SSc and disproportionally affects the limited cutaneous form of the disease and patients positive for Anticentromere Antibodies. PubMed, Rheumatology (Oxford), 08/01/2017. (Also see Interstitial Cystitis and Antibodies) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  5. Etiology, pathophysiology and biomarkers of interstitial cystitis/painful bladder syndrome. It could be suggested to classify the patients with emphasis on the phenotype, as well as their symptom clusters, to tailor the diagnostic and management choices according to the observed biomarkers. PubMed, Arch Gynecol Obstet, 04/08/2017. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  6. Intravesical liposome therapy for interstitial cystitis. The present review discusses the properties of liposomes that are important for their intrinsic therapeutic effect, summarizes the recently completed clinical studies with intravesical liposomes and covers the latest developments in this field. PubMed, Int J Urol, 2017 Apr;24(4):262-271. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  7. Strong muscles tied to lower risk of incontinence in older women. Women who have more lean muscle mass or better grip strength may be less likely to experience a common type of urinary incontinence, a study suggests. Reuters Health, 12/15/2016. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
  8. A randomized, open-label, multicenter study of the efficacy and safety of intravesical hyaluronic acid and chondroitin sulfate (HA/CS) versus dimethyl sulfoxide (DMSO) in women with bladder pain syndrome/interstitial cystitis. Treatment with HA/CS appears to be as effective as DMSO with a potentially more favorable safety profile and both treatments increased health-related quality of life. PubMed, Neurourol Urodyn, 09/21/2016. (Also see Interstitial Cystitis) This item was posted in the ISN Newsroom. Please check the newsroom daily for updates on scleroderma and other related articles.
×
×
  • Create New...